Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02573428 · ClinicalTrials.gov registry record

Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
389
Enrollment target

NCT02573428 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 389 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02573428 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
389 participants
Enrollment target

Study Summary

The primary purpose of the present study is to evaluate the diagnostic validity of eye tracking measurements acquired during viewing of socially-relevant stimuli in predicting ASD diagnosis. The secondary purpose was to explore the potential prognostic value of eye tracking measures through cross-sectional associations with non-verbal cognitive ability. Deficits in eye gaze are a hallmark sign of autism. A large and growing body of research supports the ability of eye-tracking based measurements to sensitively discriminate individuals with ASD and healthy participants. These investigations have identified that the core deficit in autism as disruption of social attention, reflecting an inability to appropriately engage and track socially- and emotionally-relevant aspects of the visual world. Thus, eye gaze tracking, acquired during viewing of socially-relevant stimuli, may be a useful approach to identifying objective markers of ASD. Eye tracking also carries the advantages of being less intrusive and expensive than MRI and genetic testing and specifically focuses on the core neurobehavioral characteristics of ASD - abnormalities in social attention. After diagnosis of ASD, key clinical tasks in young children involve determining an accurate prognosis and tracking the progress of early interventions. Currently, the only prognostic indicators are clinical observations (subjective and expensive) and non-verbal cognitive ability testing (difficult to acquire, time-consuming, unavailable in many settings). Recently, eye gaze tracking was found to predict functional outcomes. Thus, in addition to being an objective marker for ASD, eye tracking measurements have potential to be useful for predicting cognitive and functional outcomes. Similarly, the only available methods for tracking treatment progress are parental reports (highly subjective), clinical observations (subjective and expensive), and cognitive measurements (expensive and unavailable in many settings. This st

Trial Details

FieldValue
Enrollment Target 389 participants
Start Date 2015-06
Est. Completion 2016-12

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02573428

The ClinicalTrials.gov registry entry for NCT02573428 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 389 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02573428 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02573428 about?

NCT02573428 is a clinical study titled "Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder". The primary purpose of the present study is to evaluate the diagnostic validity of eye tracking measurements acquired during viewing of socially-relevant stimuli in predicting ASD diagnosis. The secondary purpose was to explore the potential prognostic value of eye tracking measures through cross-se...

What is the current status of trial NCT02573428?

This trial is currently completed. The enrollment target is 389 participants. The study started on 2015-06. Estimated completion is 2016-12.

Who is sponsoring clinical trial NCT02573428?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.